Skip to main content
# Title Research Member Research Year
71 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
72 Hypofractionation versus conventional radiotherapy
with concurrent Gemcitabine in bladder preservation of
patient with bladder carcinoma
Prof. Hamza Abbas Hamza Mohammed 2016
73 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients
Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
74 Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy Dr. Shaimaa / Elsayyed Youssef / Ahmed 2016
75 Role of 18 F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers Dr. Yasser Gaber Ali Abdelhafez 2016
76 Role of 18 F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers Dr. Yasser Gaber Ali Abdelhafez 2016
77 Non-neoplastic variants of the sternum detected on bone scintigraphy using a hybrid SPECT/CT machine Dr. Yasser Gaber Ali Abdelhafez 2016
78 The Effects Of Paraffin Wedge Filters On The Electron Beam Therapy Dr. Moamen Mohamed Omran Moustafa Aly 2016
79 Pretreatment levels of serum osteoprotegerin and p53 protein
and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients
Prof. Mohamed Ibrahim Mohamed El-Sayed 2016
80 N(2)-L-Alanyl-L-Glutamine Dipeptide Preventing Oxaliplatin-Induced Neurotoxicity in Colorectal Cancer Patients Dr. Shaimaa / Elsayyed Youssef / Ahmed 2016